V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007902 | 290005278 | 1.68 | 73 | Curative (C) | 2015-09-01 | 2015-09-10 | Capecitabine + Mitomycin | N | N | 290021435 | CARBOPLATIN + RT |
| 290007903 | 290005279 | null | 60.6 | Palliative (P) | 2017-12-19 | 2017-12-29 | Cisplatin 7 day | N | Y | 290021439 | CAPECITABINE + CISPLATIN |
| 290007904 | 290005282 | null | 128.999 | Curative (C) | 2013-03-06 | 2015-07-13 | IVADo | null | Y | 290021441 | FLUOROURACIL + MITOMYCIN |
| 290007905 | 290005284 | 1.7 | null | Adjuvant (A) | 2015-12-20 | 2016-01-10 | Capecitabine (14 days)+Carboplatin | null | null | 290021442 | CAPECITABINE + OXALIPLATIN |
| 290007906 | 290005288 | 1.47 | null | Palliative (P) | 2016-12-11 | 2016-12-25 | Cisplatin | N | null | 290021455 | CARBO + FLUOROURACIL |
| 290007907 | 290005296 | 1.6 | 50.8 | Curative (C) | 2018-04-29 | 2018-07-29 | CISPLATIN + RT | N | N | 290021487 | CAPECITABINE + MITOMYCIN + RT |
| 290007908 | 290005297 | 1.7 | 65 | Neo-adjuvant (N) | 2017-05-12 | 2017-05-21 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 290021522 | OXALIPLATIN + MDG + PANITUMUMAB |
| 290007909 | 290005301 | 1.87 | 59.8 | Disease modification (D) | 2015-07-19 | 2015-07-28 | Docetaxel + Nintedanib | N | N | 290021527 | CARBOPLATIN + PACLITAXEL |
| 290007910 | 290005304 | null | 84.3 | Palliative (P) | 2018-04-07 | 2018-04-07 | GemCarbo Days 1+8 | 02 | N | 290021535 | CARBOPLATIN |
| 290007911 | 290005306 | 1.64 | 67.6 | Palliative (P) | 2016-11-11 | 2016-11-11 | Y-90 | null | N | 290021543 | CETUXIMAB + CISPLATIN + FU |
| 290007912 | 290005310 | null | 52 | Palliative (P) | 2015-04-15 | 2015-04-19 | LANREOTIDE | 02 | N | 290021576 | LANREOTIDE |
| 290007913 | 290005311 | 1.85 | 80.7 | Curative (C) | 2013-04-22 | 2013-05-09 | Trial Unspecified | N | N | 290021588 | CAPECITABINE + MITOMYCIN + RT |
| 290007914 | 290005314 | 1.85 | 70.7 | Not known (9) | null | 2016-08-19 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 290021594 | LANREOTIDE |
| 290007915 | 290005315 | 1.8 | 74.5 | Palliative (P) | 2015-06-19 | 2015-06-24 | PACLITAXEL + TRASTUZUMAB | N | null | 290021596 | IRINOTECAN |
| 290007916 | 290005321 | null | 56.45 | Palliative (P) | 2016-09-05 | 2016-09-05 | Capecitabine | N | N | 290021610 | INTERAACT TRIAL |
| 290007917 | 290007249 | 1.74 | 52.2 | Palliative (P) | null | 2017-06-14 | Capecitabine + Mitomycin | N | N | 290021624 | CETUXIMAB |
| 290007918 | 290005324 | 1.76 | 61.2 | Curative (C) | 2018-11-09 | 2018-11-10 | CISPLATIN + RT | N | N | 290021635 | CETUXIMAB |
| 290007919 | 290007251 | 1.67 | 85 | Disease modification (D) | 2017-01-29 | 2017-07-23 | Carboplatin + Paclitaxel (3 weekly) | null | N | 290021638 | IPILIMUMAB |
| 290007920 | 290007251 | 1.6 | 58.15 | null | 2016-04-29 | 2016-05-07 | CARBOPLATIN + RT | N | N | 290021638 | FLUOROURACIL + MITOMYCIN |
| 290007921 | 290005329 | 1.71 | 85.85 | Palliative (P) | 2019-05-31 | 2019-05-31 | LANREOTIDE | 02 | N | 290021673 | CETUXIMAB |
| 290007922 | 290005330 | 1.5 | 76 | Palliative (P) | 2017-09-21 | 2017-09-24 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 290021673 | CAPECITABINE + IRINOTECAN |
| 290007923 | 290005332 | 1.76 | 74.7 | Palliative (P) | 2015-01-18 | 2015-03-03 | Cetuximab 7 day (>Cycle 2) | 2 | Y | 290021694 | LANREOTIDE |
| 290007924 | 290005333 | 1.6 | 55.9 | Palliative (P) | 2016-07-01 | 2016-10-28 | Trial Unspecified | 02 | N | 290021699 | INTERAACT TRIAL |
| 290007925 | 290005339 | 1.79 | 77.2 | Curative (C) | 2016-08-24 | 2016-08-24 | Carboplatin + Etoposide IV 3 day | Y | null | 290021733 | CETUXIMAB + RT |
| 290007926 | 290005345 | 1.75 | 69 | Palliative (P) | 2016-10-10 | 2016-10-10 | CARBOPLATIN | N | null | 290021744 | CAPECITABINE |
| 290007927 | 290005349 | 1.79 | 0 | Palliative (P) | 2018-09-12 | 2018-10-01 | Trastuzumab Subcutaneous | N | N | 290021748 | CAPECITABINE |
| 290007928 | 290005352 | 1.52 | null | Curative (C) | 2013-07-21 | 2015-03-12 | ECX | N | null | 290021751 | CARBOPLATIN + RT |
| 290007929 | 290005356 | 1.74 | 63.6 | Palliative (P) | 2012-07-29 | 2013-12-28 | Irinotecan | null | null | 290021768 | CETUXIMAB |
| 290007930 | 290005358 | 1.89 | 65 | Palliative (P) | 2018-09-10 | 2018-09-20 | INTERAACT trial | N | N | 290021770 | CAPECITABINE |
| 290007931 | 290005361 | null | null | Palliative (P) | 2017-06-04 | 2017-07-08 | CARBOPLATIN | N | Y | 290021778 | CAPECITABINE + RT |
| 290007932 | 290005362 | 1.62 | 60 | Curative (C) | 2019-02-25 | 2019-02-25 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 290021780 | METHOTREXATE INTRATHECAL |
| 290007933 | 290005366 | 1.58 | 77 | Not known (9) | 2017-06-14 | 2017-07-04 | FLUOROURACIL + Panitumumab | N | null | 290021806 | CARBOPLATIN + PACLITAXEL |
| 290007934 | 290005369 | 1.5 | 67.3 | Disease modification (D) | 2014-10-07 | 2014-11-11 | INTERAACT trial | 01 | N | 290021819 | LANREOTIDE |
| 290007935 | 290008024 | 1.6 | 65 | Palliative (P) | 2017-12-02 | 2017-12-03 | Enzalutamide | 2 | N | 290021820 | NOT MATCHED |
| 290007936 | 290005375 | 1.68 | 70 | Curative (C) | 2017-07-08 | 2017-11-24 | EOX | 02 | Y | 290021863 | CISPLATIN + RT |
| 290007937 | 290005376 | 1.83 | 83.5 | Curative (C) | 2013-09-12 | 2013-09-26 | Cisplatin | 02 | N | 290021869 | CAPECITABINE + CISPLATIN + RT |
| 290007938 | 290005378 | 1.82 | 52.2 | Palliative (P) | 2018-06-19 | 2018-07-09 | PEMBROLIZUMAB | 2 | N | 290021877 | GEMCITABINE |
| 290007939 | 290005381 | 1.47 | 58 | Palliative (P) | 2018-07-22 | 2018-08-18 | MCX | N | Y | 290021885 | SUNITINIB |
| 290007940 | 290005382 | null | 0 | Palliative (P) | 2018-11-14 | 2018-11-26 | Cisplatin + Radiotherapy | N | N | 290021886 | PACLITAXEL |
| 290007941 | 290005388 | 1.79 | null | null | 2017-07-16 | 2017-07-30 | Cisplatin + Fluorouracil + RT 5day | N | null | 290021900 | LANREOTIDE |
| 290007942 | 290005389 | null | 78.1 | null | null | 2016-11-08 | Trial Unspecified | 2 | N | 290021906 | CAPECITABINE |
| 290007943 | 290008029 | 1.55 | 72.4 | Curative (C) | null | 2018-06-08 | Cetuximab 7 day (>Cycle 2) | 02 | null | 290021918 | CISPLATIN + RT |
| 290007944 | 290005392 | null | null | null | 2017-12-07 | 2018-01-19 | Carboplatin + Paclitaxel (3 weekly) | N | N | 290021951 | LANREOTIDE |
| 290007945 | 290008418 | null | 44.1 | Palliative (P) | 2014-12-15 | 2015-02-01 | Capecitabine + Oxaliplatin 21day | N | null | 290021955 | CAPECITABINE |
| 290007946 | 290007286 | 1.68 | 58.1 | Palliative (P) | null | 2016-11-06 | MITOMYCIN | N | N | 290021981 | CAPECITABINE + OXALIPLATIN |
| 290007947 | 290005401 | 1.6 | 73.7 | Palliative (P) | null | 2017-11-03 | Cisplatin 7 day | 02 | Y | 290021999 | CAPECITABINE + CISPLATIN + STREPTOZOCIN |
| 290007948 | 290005404 | 1.62 | 60 | Adjuvant (A) | 2016-03-21 | 2016-03-21 | Cisplatin | 01 | N | 290022008 | CAPECITABINE + OXALIPLATIN |
| 290007949 | 290005406 | 1.6 | 80 | Adjuvant (A) | 2018-10-16 | 2018-11-13 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | N | N | 290022017 | CISPLATIN + ETOPOSIDE |
| 290007950 | 290007290 | 1.54 | 62.75 | Adjuvant (A) | 2015-02-04 | 2015-02-05 | Cetuximab + FLUOROURACIL | N | null | 290022022 | CAPECITABINE |
| 290007951 | 290005409 | null | 33.3 | null | 2016-11-11 | 2016-11-20 | Trial Unspecified | N | null | 290022034 | TRASTUZUMAB |